Results 171 to 180 of about 10,044,809 (291)

The enterprises costs management improvement by the use of the CBM-method

, 2018
N. Yi. Radionova
openalex   +2 more sources

β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

Molecular Oncology, EarlyView.
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero, Alejandro Belmonte‐Fernández, Mónica González‐Moreno, Laura Rodríguez‐Cordero, Begoña Pérez‐Valderrama, Joaquín Herrero‐Ruíz, Francisco Romero, Carmen Sáez, Miguel Á. Japón   +8 more
wiley   +1 more source

Underlying Tremor Improvement with Consistent Use of Transcutaneous Afferent Patterned Stimulation in Patients with Essential Tremor. [PDF]

Tremor Other Hyperkinet Mov (N Y)
Isaacson SH, Peckham E, Tse W, Petrossian MT, Soileau MJ, Lew M, Dietiker C, Luthra N, Agarwal P, Dhall R, Morgan J, Shamim EA, Shill HA, Pagan FL, Khemani P, Tate J, Luo L, Ondo W, Hallett M, Lu C, Rosenbluth KH, Delp SL, Pahwa R.   +22 more
europepmc   +1 more source

Multimodal Embolization Spheres for Radiotherapy and Interventional Radiology Improvement

, 2019
Séverine Lechevallier, Thomas Lacornerie, Robin Garcia, Boris Guiu, Xavier Mirabel, Julien Santelli, Cyril Martinez, Marine Vincent, Daniel Cussac, Laurent Marescaux, Robert Mauricot, Marc Verelst   +11 more
openalex   +1 more source

Building on improvement [PDF]

, 2002

core  

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Proinflammatory state and metabolic dysregulation linking delayed feeding progression to extrauterine restricted head growth in extremely preterm infants. [PDF]

BMC Med
Chen CC, Lin YC, Lee CY, Kuo CC, Chang TH, Huang CC.   +5 more
europepmc   +1 more source

Analysis of Educators and Education Staff Management in Primary School Quality Improvement

, 2019
Cucun Sunaengsih, Jamil Jatnika, Silvy Lafthi Alifia, Latifah Latifah, Endang Solihah   +4 more
openalex   +2 more sources

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Improvement in avoidance in major depressive disorder: A 10-month prospective study of depressive symptoms and personality traits. [PDF]

PCN Rep
Higuchi R, Nakagawa A, Mitsuda D, Nogami W, Amano M, Ihara S, Ito A, Noda S, Katayama N, Kocha H.   +9 more
europepmc   +1 more source